Company Filing History:
1 out of 832,843 Years Active: 2002
Title: The Innovations of Sarah B Tencza
Introduction
Sarah B Tencza is an accomplished inventor based in Pittsburgh, PA (US). She has made significant contributions to the field of diagnostics, particularly in relation to equine health. Her innovative work has led to the development of a patented assay that enhances the detection of equine infectious anemia virus.
Latest Patents
Sarah holds a patent for a fluorescence polarization-based diagnostic assay for equine infectious anemia virus. This assay utilizes a short peptide reagent probe derived from a conserved immunodominant region of gp45. The probe is N-terminally labeled, preferably with 6-carboxyfluorescein, and purified by HPLC. It reacts in a homogenous assay with anti-EIAV antibodies contained in the serum of field-infected horses and ponies. The assay boasts a sensitivity of about 90 percent with a specificity approaching 100 percent. This innovation represents a significant advancement in veterinary diagnostics.
Career Highlights
Throughout her career, Sarah has demonstrated a commitment to improving equine health through innovative diagnostic solutions. Her work has not only contributed to the scientific community but has also had a practical impact on the care of horses affected by infectious diseases.
Collaborations
Sarah has collaborated with notable colleagues, including Ronald C Montelaro and Michael E Jolley. These partnerships have further enriched her research and development efforts, leading to advancements in diagnostic technologies.
Conclusion
In summary, Sarah B Tencza is a pioneering inventor whose work in developing a fluorescence polarization-based diagnostic assay has made a significant impact on equine health diagnostics. Her contributions continue to influence the field and improve the lives of horses affected by infectious diseases.